医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

“Ninja Diet” by Sideranch Inc. Published: Learn the Secrets of Dieting as a Ninja

2021年09月29日 PM11:00
このエントリーをはてなブックマークに追加


 

TOKYO

Sideranch Inc.’s book “Ninja Diet” is available in English on Kindle starting from September, 2021.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210929005023/en/

Ninja Diet: Learn the Secrets of Dieting as a Ninja (Graphic: Business Wire)

Ninja Diet: Learn the Secrets of Dieting as a Ninja (Graphic: Business Wire)

There are many dieting methods in the world that pretend to be “easy to lose weight”, but a truly correct diet is not easy and requires self-management and training. Instead of relying on an easy diet method, first understand and control yourself, endure everything and train.

This is the basis of a ninja.

This book is different from the easy diet methods that overflow the bookshelves. It is a secret book that those who aspire to diet should read first, face the truth of the diet, propose the correct attitude, and then start the natural weight loss.

Learning the spirit of a ninja (NIN) and the way of life, which is painless to endure, is the first secret that a diet-minded person (JA) should learn.

To become a ninja, you need to understand your movements, metabolism, breathing, sleep, and every bite of food. In addition to these, you need to take control of your daily life and “survive.”

When you read this book and become a diet aspirant, you will start your journey to become a ninja.

You can get your Ninja Diet e-book from Amazon.

About The Author

Mitsue Ueda
Doctor of Medicine / Medical Journalist

In addition to teaching at university, Mitsue Ueda supervises medical programs, and she is a TV commentator for “Health Examination of Great People” by NHK/BS. Her other books include Health of the Sengoku Period Warlords and Health Study of Edo Period.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210929005023/en/

CONTACT

Sideranch Inc.

+81 3-5256-1003

Buse Alan

alanbuse@sideranch.co.jp

同じカテゴリーの記事 

  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024
  • Kolmar Korea Wins Case Against Italian Cosmetics Maker Intercos for Suncare Technology Theft
  • 大手CDMOのPCIファーマ・サービシズが初の包括ESG報告書を発表